Non-invasive Screening Isomark offers a patented non-invasive breath-based diagnostic platform that delivers real-time infection detection at the Chute site, presenting a compelling value proposition for farms seeking rapid on-site health monitoring and reduced lab turnaround.

Sustainability & Antibiotics The technology aims to reduce antibiotic usage by enabling targeted treatment, which can improve meat quality and align with growing demand for sustainable livestock practices, creating a selling point for retailers and producers focused on responsible farming.

Untapped Market With an addressable risk pool of one million beef cattle in the US facing bovine respiratory disease, Isomark can target large-scale operations and feedlots that rely on fast decision-making to minimize mortality and morbidity costs.

Strategic Partnerships Recent addition of advisors and board members signals a move toward formal partnerships and collaborations; identify potential integrations with veterinary networks, animal health suppliers, and farm management platforms to accelerate adoption.

Growth Readiness Current revenue under one million and total funding of three million plus indicate a growing start-up poised for pilot programs and regional deployments; opportunities exist to offer pilot quotes, channel partnerships, and co-marketing with complementary tech providers.